---
title: "Hepion Pharmaceuticals (HEPA.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/HEPA.US/norm.md"
symbol: "HEPA.US"
name: "Hepion Pharmaceuticals"
parent: "https://longbridge.com/zh-CN/quote/HEPA.US.md"
datetime: "2026-05-21T16:11:21.210Z"
locales:
  - [en](https://longbridge.com/en/quote/HEPA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HEPA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HEPA.US/norm.md)
---

# Hepion Pharmaceuticals (HEPA.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0700 | -0.0563 | -0.0407 | -0.0920 | -2.15 |
| ROE | -571.96% | -201.98% | -101.31% | -193.84% | 3598.23% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -810791.00 | -656885.00 | -472506.00 | -1.04M | -6.11M |
| 营业利润 | -798509.00 | -609683.00 | -527902.00 | -1.34M | -1.28M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | -138.01% | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 2.71M | 3.07M | 3.74M | 4.51M | 6.32M |
| 权益乘数 | 1.46 | 1.15 | 1.13 | 1.19 | 1.62 |
| 每股净资产 | 0.0139 | 0.0837 | 0.1402 | 0.1809 | 0.2295 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 2.60M | 1.83M | 2.32M | 2.92M | 4.59M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | - | - | - | - |
| 净债务 | -2.60M | -1.77M | -2.11M | -2.55M | -4.06M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | 578584.00 | -332775.00 | -445963.00 | -1.38M | -1.12M |
| 投资现金流 | - | 0.0000 | 0.0000 | -132117.00 | - |
| 融资现金流 | 195934.00 | -160241.00 | -157354.00 | -154517.00 | 5.30M |
| 自由现金流 | 1.13M | -91565.00 | -256118.00 | -1.01M | -1.14M |
| 现金流充裕率 | 1070.14% | -207.67% | -283.41% | -890.10% | -38.53% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |